← Back to Search

Participant intervention for Cervical Cancer

N/A

Waitlist Available

Research Sponsored by Boston University Charles River Campus

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 18+

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up start of the intervention and about 1-2 months after the start of intervention

Awards & highlights

Study Summary

This trial aims to develop a new intervention to increase awareness and address the factors contributing to cervical cancer development in cisgender individuals with cervixes and women with HIV. The first part of the trial involves

Who is the study for?

This trial is for cisgender individuals with cervixes and women living with HIV in South Africa who have recently had a high-risk abnormal Pap smear. Participants should either have attended at least one follow-up visit or not yet attended any. The study aims to help them keep up with cervical cancer care appointments.Check my eligibility

What is being tested?

The trial is developing an intervention that includes both patient- and provider-level components to improve retention in cervical cancer care among women with HIV. It involves interviews, creating a brief patient intervention, a provider toolkit, and testing these tools' feasibility and acceptability.See study design

What are the potential side effects?

Since this study focuses on interventions related to attendance and awareness rather than medical treatments, traditional side effects are not applicable. However, participants may experience emotional or psychological impacts from discussing sensitive health issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ about 1-2 months after the start of intervention and at about 7 months after the start of the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~about 1-2 months after the start of intervention and at about 7 months after the start of the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and about 1-2 months after the start of intervention and at about 7 months after the start of the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of the intervention

Feasibility of the intervention

Secondary outcome measures

Follow-up appointment attendance

Self-efficacy to attend cervical cancer-related health care appointment

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Participant interventionExperimental Treatment1 Intervention

The intervention group will likely consist of one to two sessions, conducted in-person, coupled with text- or phone-based client navigation.The intervention group will complete three major assessments: baseline (T1), at the conclusion of the intervention (T2), and a six-month follow-up (T3). Until the follow-up assessment, the interventionist will send participants up to 6 SMS messages (one-way) per month. The content of these messages will be developed collaboratively between the participant and the interventionist during the second session; messages could include reminders about follow-ups and/or prompts to use new skills and resources for navigating specific barriers.

Group II: Treatment as usualActive Control1 Intervention

The treatment as usual (TAU) group will receive treatment as usual, including being notified of their abnormal Pap results via SMS and instructed to set up a follow-up appointment, as is typical in routine care. The TAU group will complete the T1 assessment and will complete T2 assessment two-months post-baseline.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Boston University Charles River CampusLead Sponsor

114 Previous Clinical Trials

12,210 Total Patients Enrolled

Massachusetts General HospitalOTHER

2,936 Previous Clinical Trials

13,198,641 Total Patients Enrolled

University of Witwatersrand, South AfricaOTHER

98 Previous Clinical Trials

9,944,256 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for patient participation in this clinical trial?

"As per the information provided on clinicaltrials.gov, this particular clinical trial is not currently accepting new participants. The trial was initially posted for recruitment purposes on March 1st, 2024 and underwent its last update on December 13th, 2023. However, it's worth noting that there are presently 507 other ongoing clinical trials actively seeking eligible participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2

Amelia M. Stanton 2024. "Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06182241.

All > Womens Health > Cervical Cancer